265 related articles for article (PubMed ID: 21145823)
1. Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver.
Iacobini C; Menini S; Ricci C; Blasetti Fantauzzi C; Scipioni A; Salvi L; Cordone S; Delucchi F; Serino M; Federici M; Pricci F; Pugliese G
J Hepatol; 2011 May; 54(5):975-83. PubMed ID: 21145823
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis.
Jeftic I; Jovicic N; Pantic J; Arsenijevic N; Lukic ML; Pejnovic N
Mol Med; 2015 May; 21(1):453-65. PubMed ID: 26018806
[TBL] [Abstract][Full Text] [Related]
3. Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms.
Iacobini C; Menini S; Ricci C; Scipioni A; Sansoni V; Mazzitelli G; Cordone S; Pesce C; Pugliese F; Pricci F; Pugliese G
J Pathol; 2009 Jul; 218(3):360-9. PubMed ID: 19334049
[TBL] [Abstract][Full Text] [Related]
4. The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis.
Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Salvi L; Pesce CM; Relucenti M; Familiari G; Taurino M; Pugliese G
Cardiovasc Res; 2013 Dec; 100(3):472-80. PubMed ID: 23975852
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.
Pejnovic N; Jeftic I; Jovicic N; Arsenijevic N; Lukic ML
World J Gastroenterol; 2016 Nov; 22(44):9706-9717. PubMed ID: 27956794
[TBL] [Abstract][Full Text] [Related]
7. Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms.
Iacobini C; Menini S; Ricci C; Scipioni A; Sansoni V; Cordone S; Taurino M; Serino M; Marano G; Federici M; Pricci F; Pugliese G
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):831-6. PubMed ID: 19359660
[TBL] [Abstract][Full Text] [Related]
8. Therapy of experimental NASH and fibrosis with galectin inhibitors.
Traber PG; Zomer E
PLoS One; 2013; 8(12):e83481. PubMed ID: 24367597
[TBL] [Abstract][Full Text] [Related]
9. Deficiency in galectin-3 promotes hepatic injury in CDAA diet-induced nonalcoholic fatty liver disease.
Nomoto K; Nishida T; Nakanishi Y; Fujimoto M; Takasaki I; Tabuchi Y; Tsuneyama K
ScientificWorldJournal; 2012; 2012():959824. PubMed ID: 22593713
[TBL] [Abstract][Full Text] [Related]
10. Isoquercitrin attenuates the progression of non-alcoholic steatohepatitis in mice by modulating galectin-3-mediated insulin resistance and lipid metabolism.
Jin HL; Feng XY; Feng SL; Dai L; Zhu WT; Yuan ZW
Phytomedicine; 2024 Jan; 123():155188. PubMed ID: 38056146
[TBL] [Abstract][Full Text] [Related]
11. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
[TBL] [Abstract][Full Text] [Related]
12. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model.
Rein-Fischboeck L; Haberl EM; Pohl R; Schmid V; Feder S; Krautbauer S; Liebisch G; Buechler C
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):526-537. PubMed ID: 29474931
[TBL] [Abstract][Full Text] [Related]
13. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte-specific loss of LAP2α protects against diet-induced hepatic steatosis, steatohepatitis, and fibrosis in male mice.
Upadhyay KK; Choi EK; Foisner R; Omary MB; Brady GF
Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G184-G195. PubMed ID: 37366543
[TBL] [Abstract][Full Text] [Related]
15. Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8
Rein-Fischboeck L; Haberl EM; Bajraktari G; Feder S; Pohl R; Eggenhofer E; Buechler C
Exp Mol Pathol; 2020 Apr; 113():104363. PubMed ID: 31881201
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.
Bettaieb A; Jiang JX; Sasaki Y; Chao TI; Kiss Z; Chen X; Tian J; Katsuyama M; Yabe-Nishimura C; Xi Y; Szyndralewiez C; Schröder K; Shah A; Brandes RP; Haj FG; Török NJ
Gastroenterology; 2015 Aug; 149(2):468-80.e10. PubMed ID: 25888330
[TBL] [Abstract][Full Text] [Related]
17. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
Matsuzawa N; Takamura T; Kurita S; Misu H; Ota T; Ando H; Yokoyama M; Honda M; Zen Y; Nakanuma Y; Miyamoto K; Kaneko S
Hepatology; 2007 Nov; 46(5):1392-403. PubMed ID: 17929294
[TBL] [Abstract][Full Text] [Related]
18. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
20. Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice.
Iacobini C; Oddi G; Menini S; Amadio L; Ricci C; Di Pippo C; Sorcini M; Pricci F; Pugliese F; Pugliese G
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F611-21. PubMed ID: 15870382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
